These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15501349)

  • 21. Statin therapy in the elderly: a review.
    Szadkowska I; Stanczyk A; Aronow WS; Kowalski J; Pawlicki L; Ahmed A; Banach M
    Arch Gerontol Geriatr; 2010; 50(1):114-8. PubMed ID: 19217673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Do statins have a place for cardiovascular prevention in elderly people?].
    Petermans J; Laperche J; Scheen AJ
    Rev Med Liege; 2006; 61(5-6):386-93. PubMed ID: 16910266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Statins under fire: justified or not?].
    Declerck E; De Loof H; De Meyer GR
    J Pharm Belg; 2009 Dec; (4):119-30. PubMed ID: 20183988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
    Yokoyama M; Origasa H;
    Am Heart J; 2003 Oct; 146(4):613-20. PubMed ID: 14564313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
    Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
    J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins in Persons at Low Risk of Cardiovascular Disease.
    Abramson J
    Am Fam Physician; 2017 Nov; 96(9):Online. PubMed ID: 29094882
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lowering cholesterol in the elderly--yes, no, or maybe?].
    Gogol M
    MMW Fortschr Med; 2006 Mar; 148(12):40-3. PubMed ID: 16626005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Statins and stroke].
    Chudzik W; Kaczorowska B; Chmielewski H; Przybyła M; Gałka M
    Pol Merkur Lekarski; 2005 Oct; 19(112):591-5. PubMed ID: 16379334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins and primary prevention: is all the evidence in?
    Rashid S; Francis GA
    Can J Cardiol; 2008 Apr; 24(4):301-3. PubMed ID: 18401471
    [No Abstract]   [Full Text] [Related]  

  • 31. [No reason to start treatment with statins in patients with moderate to severe heart failure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):486-8. PubMed ID: 18389878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues.
    Moride Y; Hegele RA; Langer A; McPherson R; Miller DB; Rinfret S
    Can J Cardiol; 2008 Apr; 24(4):293-300. PubMed ID: 18401470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment with hydroxymethylglutaryl coenzyme-A-reductase inhibitors in elderly patients: is it necessary?].
    Alexa ID; Panaghiu L; Ungureanu G
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):721-6. PubMed ID: 16610166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Statins and prevention of strokes].
    Neau JP; Moumy H; Mathis S; Gil R
    Rev Neurol (Paris); 2005 Feb; 161(2):237-44. PubMed ID: 15798527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug Insight: statins and stroke.
    Sacco RL; Liao JK
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):576-84. PubMed ID: 16258569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
    Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
    Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update for primary healthcare providers: recent statin trials and revised National Cholesterol Education Program III guidelines.
    Hennekens CH; Hollar D; Eidelman RS; Agatston AS
    MedGenMed; 2006 Feb; 8(1):54. PubMed ID: 16915184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence.
    Ali R; Alexander KP
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):52-63. PubMed ID: 17608248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.